• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猿猴病毒40大T抗原可抑制哺乳动物DNA拓扑异构酶I的活性以及喜树碱对其的中毒作用。

Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen.

作者信息

Pommier Y, Kohlhagen G, Wu C, Simmons D T

机构信息

Laboratory of Molecular Pharmacology, National Cancer Institute, Bethesda, Maryland 20892-4255, USA.

出版信息

Biochemistry. 1998 Mar 17;37(11):3818-23. doi: 10.1021/bi972067d.

DOI:10.1021/bi972067d
PMID:9521701
Abstract

DNA topoisomerase I (top1) is a ubiquitous enzyme that forms reversible DNA single-strand breaks (cleavage complexes) and plays a role in transcription, DNA replication, and repair. Top1 is the target of camptothecins which selectively trap top1 cleavage complexes and represent a novel class of anticancer drugs active against human solid tumors. The present study demonstrates that recombinant large T antigen (T-Ag), a virus encoded helicase with strong affinity for tumor suppressors and cell cycle- and replication-related proteins, suppresses top1 cleavage complexes and top1 catalytic activity. This top1 suppressive activity is probably not due to T-Ag binding to DNA, as a T-Ag truncation mutant containing only the first 246 amino acids and deficient in DNA binding also inhibited top1, and the inhibition was independent of ATP. T-Ag also antagonized and reversed the trapping of top1 cleavage complexes by camptothecin. These results demonstrate a functional interaction between T-Ag and top1: they also suggest the importance of top1-protein interactions for the regulation of DNA replication and modulation of camptothecin activity.

摘要

DNA拓扑异构酶I(top1)是一种普遍存在的酶,它能形成可逆的DNA单链断裂(切割复合物),并在转录、DNA复制和修复过程中发挥作用。Top1是喜树碱的作用靶点,喜树碱能选择性地捕获top1切割复合物,是一类对人类实体瘤有效的新型抗癌药物。本研究表明,重组大T抗原(T-Ag)是一种病毒编码的解旋酶,对肿瘤抑制因子以及细胞周期和复制相关蛋白具有很强的亲和力,它能抑制top1切割复合物和top1的催化活性。这种top1抑制活性可能不是由于T-Ag与DNA结合所致,因为一个仅包含前246个氨基酸且缺乏DNA结合能力的T-Ag截短突变体也能抑制top1,并且这种抑制作用与ATP无关。T-Ag还能拮抗并逆转喜树碱对top1切割复合物的捕获。这些结果证明了T-Ag与top1之间存在功能相互作用:它们还表明top1-蛋白质相互作用对于DNA复制调控和喜树碱活性调节的重要性。

相似文献

1
Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen.猿猴病毒40大T抗原可抑制哺乳动物DNA拓扑异构酶I的活性以及喜树碱对其的中毒作用。
Biochemistry. 1998 Mar 17;37(11):3818-23. doi: 10.1021/bi972067d.
2
Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I.茚并异喹啉MJ-III-65(NSC 706744)和喜树碱对拓扑异构酶I-DNA切割复合物的差异诱导:碱基序列分析及对喜树碱抗性拓扑异构酶I的活性
Cancer Res. 2003 Nov 1;63(21):7428-35.
3
Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.来自一株喜树碱耐药性人前列腺癌细胞系的新型拓扑异构酶I突变的特征分析
Cancer Res. 2001 Mar 1;61(5):1964-9.
4
Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.喜树碱与DNA拓扑异构酶I三元可裂解复合物的分子模拟研究
J Med Chem. 1998 Jun 18;41(13):2216-26. doi: 10.1021/jm9605445.
5
Enhanced CPT sensitivity of yeast cells and selective relaxation of Ga14 motif-containing DNA by novel Gal4-topoisomerase I fusion proteins.新型Gal4-拓扑异构酶I融合蛋白增强酵母细胞的CPT敏感性并选择性松弛含Gal4基序的DNA。
J Mol Biol. 2004 Mar 19;337(2):295-305. doi: 10.1016/j.jmb.2004.01.032.
6
Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.鉴定哺乳动物DNA拓扑异构酶I为抗癌药物喜树碱的细胞内靶点。
Cancer Res. 1988 Apr 1;48(7):1722-6.
7
Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.E2F-1/DP-1转录因子复合物过表达后拓扑异构酶I和II抗癌药物的差异细胞毒性途径
Clin Cancer Res. 2000 Apr;6(4):1488-97.
8
Mechanisms of resistance to topoisomerase I-targeting drugs.对靶向拓扑异构酶I药物的耐药机制。
Oncogene. 2003 Oct 20;22(47):7296-304. doi: 10.1038/sj.onc.1206935.
9
Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site.使用喜树碱抗性哺乳动物细胞系评估拓扑异构酶I在吲哚咔唑NB - 506的抗增殖活性及其拓扑异构酶I结合位点中的作用。
Cancer Res. 2001 Jan 15;61(2):504-8.
10
Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system.复制叉与拓扑异构酶I-DNA可切割复合物之间的相互作用:在无细胞SV40 DNA复制系统中的研究
Cancer Res. 1993 Dec 15;53(24):5908-14.

引用本文的文献

1
(S)-10-Hydroxycamptothecin Inhibits EMT-evoked Osteosarcoma Cell Growth and Metastasis by Activating the HIPPO Signaling Pathway.(S)-10-羟基喜树碱通过激活 Hippo 信号通路抑制 EMT 诱导的骨肉瘤细胞生长和转移。
Comb Chem High Throughput Screen. 2024;27(15):2239-2248. doi: 10.2174/0113862073263020231220043405.
2
TDP1-independent pathways in the process and repair of TOP1-induced DNA damage.TOP1 诱导的 DNA 损伤的过程和修复中 TDP1 非依赖性途径。
Nat Commun. 2022 Jul 22;13(1):4240. doi: 10.1038/s41467-022-31801-7.
3
Roles of eukaryotic topoisomerases in transcription, replication and genomic stability.
真核生物拓扑异构酶在转录、复制和基因组稳定性中的作用。
Nat Rev Mol Cell Biol. 2016 Nov;17(11):703-721. doi: 10.1038/nrm.2016.111. Epub 2016 Sep 21.
4
Nucleolin inhibits G4 oligonucleotide unwinding by Werner helicase.核仁素抑制 Werner 解旋酶解开 G4 寡核苷酸。
PLoS One. 2012;7(6):e35229. doi: 10.1371/journal.pone.0035229. Epub 2012 Jun 4.
5
Simian virus 40 DNA replication is dependent on an interaction between topoisomerase I and the C-terminal end of T antigen.猿猴病毒40(Simian virus 40)的DNA复制依赖于拓扑异构酶I与T抗原C末端之间的相互作用。
J Virol. 2008 Feb;82(3):1136-45. doi: 10.1128/JVI.01314-07. Epub 2007 Nov 14.
6
Repair of topoisomerase I-mediated DNA damage.拓扑异构酶I介导的DNA损伤修复。
Prog Nucleic Acid Res Mol Biol. 2006;81:179-229. doi: 10.1016/S0079-6603(06)81005-6.
7
Potential protein partners for the N-terminal domain of human topoisomerase I revealed by phage display.通过噬菌体展示揭示的人类拓扑异构酶I N端结构域的潜在蛋白质伴侣。
Mol Biol Rep. 2002 Dec;29(4):347-52. doi: 10.1023/a:1021237021338.
8
Characterization of BTBD1 and BTBD2, two similar BTB-domain-containing Kelch-like proteins that interact with Topoisomerase I.BTBD1和BTBD2的特性,两种与拓扑异构酶I相互作用的含BTB结构域的类似kelch样蛋白。
BMC Genomics. 2002;3:1. doi: 10.1186/1471-2164-3-1. Epub 2002 Jan 7.
9
Transcriptional consequences of topoisomerase inhibition.拓扑异构酶抑制的转录后果。
Mol Cell Biol. 2001 Dec;21(24):8437-51. doi: 10.1128/MCB.21.24.8437-8451.2001.
10
Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoff.通过复制延伸,核糖体DNA前导链上的拓扑异构酶I切割复合物转化为5'-磷酸化DNA双链断裂。
Mol Cell Biol. 2000 Jun;20(11):3977-87. doi: 10.1128/MCB.20.11.3977-3987.2000.